Will bhvn go up today

Biohaven (BHVN) is expected to experience an upward trend today. Here's the analysis to support this conclusion:

1. Recent Performance: BHVN has shown a strong upward trend, with an 18.54% interval percentage change over the past week and an 11.92% interval percentage change over the past month. This indicates a recent surge in the stock's value.

2. Short-term Trend Forecast: The short-term trend forecast for BHVN is not available, but the recent performance suggests that the stock is likely to continue its upward momentum.
3. Moving Averages: The 5-day moving average is $46.07, and the 10-day moving average is $41.16. The fact that the stock is currently above these short-term moving averages suggests a bullish trend.

4. Technical Indicators: The stock's MACD is 2.18, KDJ is 79.36, and RSI is 81.59, which suggests that the stock is in an overbought territory but still has momentum.

5. Market Sentiment: The stock has received positive ratings from analysts, with HC Wainwright reaffirming a "buy" rating and setting a $59.00 price target, and Royal Bank of Canada raising its target price to $68.00. This indicates a positive sentiment among analysts.
6. Upcoming Catalysts: BHVN has several upcoming catalysts, including the submission of a new drug application (NDA) for troriluzole in SCA, which could lead to potential FDA approval and market launch.

In conclusion, the recent strong performance, positive technical indicators, and favorable market sentiment suggest that BHVN is likely to continue its upward trend today.